PANK-003 Cell Injection Combined With Standard Adjuvant Chemotherapy After Surgery in Patients With Stage IIIA NSCLC

Clinical trial NCT07043907 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07043907
Sponsor: Shenzhen Celconta Life Science Co., Ltd.
Status: NOT_YET_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Stage IIIA Non-small Cell Lung Cancer

Start date: 2025-07-08
Primary completion: 2028-07-08
Enrollment: 115

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.